Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
6 hedge funds and large institutions have $174K invested in Genetic Technologies Ltd. in 2013 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
Aperio Group
Sausalito,
California
| $84K | +$94.2K | +363 | New |
|
|
KCG
2
Knight Capital Group
| $33K | +$36.8K | +142 | New |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $27K | +$29.6K | +114 | New |
|
|
APU
4
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $23K | +$26.2K | +101 | New |
|
5
Group One Trading
Chicago,
Illinois
| $6K | +$7K | +27 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1K | +$1.3K | +5 | New |
|
GENE Hedge Fund Activity: Q2 2013 in Review
6 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2013, worth a combined $174K.
Buyers outnumbered sellers: 6 funds opened new GENE positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
- 6 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $174K of Genetic Technologies Ltd. stock for Q2 2013.
- 6 funds opened new Genetic Technologies Ltd. positions in Q2 2013 and 0 closed out, a net change of +6 holders.
Based on aggregated 13F filings for Q2 2013.